Angela Crawley
Ph.D.
Senior Scientist, Inflammation and Chronic Disease
Ottawa Hospital Research Institute
Assistant Professor, Biochem.
Microbiol.
Adjunct Professor, Biology
Carleton University
Contact
613-737-8673
Fax: 613-737-8803 Administrative Assistant: Faith Izevbizua (fizevbizua@ohri.ca)
Research Groups
Crawley Lab
Bio
Dr. Crawley has been with the Chronic Diseases Program at the Ottawa Hospital Research Institute since April 2012. In addition to being a Scientist with the OHRI, she is also an Assistant Professor at the University of Ottawa and an Adjust Professor at Carleton University, where she teaches immunology at the undergraduate, graduate and medical school levels. She teaches these courses in both English and French. Dr. Crawley has earned 2 salary awards: a CIHR New Investigator Award and an Ontario HIV Treatment Network (OHTN) Junior Investigator Development Award. Her research is funded by the OHTN, Canadian Foundation of AIDS Research and the J.P. Bickell Medical Research Foundation.
Dr. Crawley received a B.Sc. in Microbiology and Immunology from McGill University in Montreal, Quebec (Canada) in 1999. In 2004 she completed a Ph.D. in Immunology with Dr. Bruce N. Wilkie in the Dept. of Pathobiology at the University of Guelph’s Ontario Veterinary College (Guelph, Ontario, Canada). Dr. Crawley then trained as a postdoctoral fellow in Dr. Jonathan B. Angel’s laboratory at the Ottawa Hospital Research Institute, and published 10 peer-reviewed scientific research and review articles on the immunopathogenesis of HIV infection. Dr. Crawley was funded by an Ontario HIV Treatment Network (OHTN) Fellowship award and awarded a University of Ottawa Faculty of Medicine Postdoctoral Award of Excellence (2007).
For more information including a list of courses taught, please visit: http://www.crawleylab.ca/
News
Publications
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)
2023-02-01 Go to publicationThe 9th Canadian Symposium on Hepatitis C Virus: Advances in HCV research and treatment towards elimination
2020-01-01Selective killing of human M1 macrophages by Smac mimetics alone and M2 macrophages by Smac mimetics and caspase inhibition
2020-01-01Expression of Inhibitory Receptors on T and NK Cells Defines Immunological Phenotypes of HCV Patients with Advanced Liver Fibrosis
2020-01-01